We are live on ! Find out more
IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

16 hedge funds and large institutions have $221K invested in ImmunoCellular Therapeutics, Ltd. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

6% less funds holding

Funds holding: 1716 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

79% less capital invested

Capital invested by funds: $1.04M → $221K (-$818K)

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$112K +$24.2K +14,800 +13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$55K +$12.6K +7,700 +14%
WS
3
Wedbush Securities
California
$32K +$61.3K +37,500 New
VKH
4
Virtu KCG Holdings
New York
$12K +$23.2K +14,163 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$9K
BlackRock
6
BlackRock
New York
$1K
SM
7
Sabby Management
Florida
-$445K -139,912 Closed
IP
8
Intellectus Partners
California
-$9K -2,707 Closed
Morgan Stanley
9
Morgan Stanley
New York
-$101 -62 -20%
Manulife (Manufacturers Life Insurance)
10
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$8 +5 +10%